Intuit falls after fiscal 2027 guidance lands below estimates
Intuit shares dropped 11.7% in pre-market trading after the company reported fourth-quarter revenue of $4.35 billion and adjusted EPS of $4.03, both above estimates, but issued fiscal 2027 guidance below forecasts.
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday.
Shares of Intuit Inc (NASDAQ: INTU ) fell sharply in pre-market trading after the company reported upbeat fourth-quarter financial results but issued FY27 guidance below estimates.
Intuit reported fourth-quarter revenue of $4.35 billion, beating analyst estimates of $4.27 billion.
The QuickBooks, Credit Karma and TurboTax parent company posted adjusted earnings of $4.03 per share for the quarter, beating estimates of $3.58 per share, according to Pro.
Intuit expects fiscal 2027 revenue of $23.28 billion to $23.51 billion versus estimates of $23.74 billion.
The company expects full-year adjusted earnings of 22.88 to $23.12 per share versus estimates of $27.31 per share.
The earnings guidance includes a $5.81 impact from share-based compensation expenses, so estimates may not be comparable.
Intuit also noted that Mailchimp will become a separate reportable segment beginning in fiscal 2027.
Intuit shares dipped 11.7% to $315.50 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
Advasa Holdings (NASDAQ: ADBT ) shares dipped 14.1% to $5.38 in pre-market trading after dipping around 48% on Tuesday.
Advasa Holdings, on Tuesday, completed a direct listing on Nasdaq under the ticker symbol “ADBT”.
Spyre Therapeutics Inc (NASDAQ: SYRE ) declined 12.3% to $94.16 in pre-market trading after the company announced topline results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases.
The results did not meet the company’s internal bar to prioritize advancement of SPY072 in RA.
Q fin Holdings Inc — ADR (NASDAQ: QFIN ) dropped 9.8% to $10.40 in pre-market trading after the company reported a year-over-year decrease in second-quarter financial results.
Digital Currency X Technology Inc (NASDAQ: DCX ) fell 7.5% to $0.90 in pre-market trading following a 2% decline on Tuesday.
Ultrapar Participacoes SA (NYSE: UGP ) fell 6% to $6.30 in pre-market trading.
Zoom Communications Inc (NASDAQ: ZM ) fell 5.8% to $95.10 in pre-market trading as the company reported better-than-expected financial results for the second quarter but issued soft guidance for the third quarter.
Frontline Plc (NYSE: FRO ) fell 5% to $41.32 in pre-market trading.
SAP SE (NYSE: SAP ) declined 4.6% to $207.00 in pre-market trading.
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX ) declined 4.3% to $9.41 in pre-market trading.
BioCryst, on Tuesday, announced the approval of ORLADEYO for pediatric HAE patients in Japan.
BW LPG Ltd (NYSE: BWLP ) fell 4.1% to $23.79 in pre-market trading after gaining around 5% on Tuesday.
Photo via Shutterstock